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Abstract  
Research has shown that intensive, brief formats of exposure therapy and cognitive 
(behavioural) therapy for PTSD are well tolerated and effective. This pilot study examined the 
effectiveness of an intensive EMDR treatment program for PTSD, comorbid disorders and its 
effect on the level of psychological distress. Patients (n = 7) were hospitalised for five days, 
during which they received EMDR sessions twice a day, except for the first day on which 
they had one EMDR session. One week after the hospitalisation they received a follow-up 
EMDR session. PTSD symptoms were assessed with the CAPS-5 and the PCL-5. The MINI 
was used to assess comorbid disorders and psychological distress was assessed with the BSI. 
The CAPS-5, the PCL-5, the MINI and the BSI were administered before the treatment and 
two weeks after the hospitalisation. The PCL-5 was also administered at hospitalisation day 
one, hospitalisation day 5 and after the follow-up EMDR session, to monitor treatment 
progress. The results of this study show that the treatment program reduces all PTSD 
symptoms. On the PCL-5, patients report significantly less avoidance and arousal symptoms. 
The treatment also has an effect on comorbid depressive, anxiety and substance use disorders 
and it significantly reduces overall psychological distress, anxiety, hostility and psychoticism. 
This pilot study shows that an intensive EMDR treatment program can be an effective 
treatment for PTSD and comorbid disorders, but more research is needed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
1 Introduction 
This pilot study examines the effectiveness of an intensive Eye Movement Desensitisation 
Reprocessing (EMDR) treatment for Post Traumatic Stress Disorder (PTSD) and comorbid 
disorders. This chapter starts with a description of what a PTSD is, based on the DSM 5 
(paragraph 1.1). Thereafter, a recommended treatment for PTSD, EMDR, is described 
(paragraph 1.2). The third paragraph of this chapter is about trauma-Sensitive Yoga (TSY), 
which was also incorporated in the treatment program. Research on intensive treatment 
formats for PTSD is summarized in paragraph 1.4. The chapter concludes with an outline of 
the pilot study of intensive EMDR treatment for PTSD (paragraph 1.5). 
 
1.1 Post traumatic stress disorder 
In the mid-nineteenth century, psychiatrists and other physicians began to describe syndromes 
among combat veterans and civilians that cover many current PTSD symptoms and different 
theories about mechanisms through which traumatic stress might lead to PTSD were proposed 
(Van Der Kolk, Herron, & Hostetler, 2007). The DSM-I already had a diagnosis concerning 
traumatic stress and the initial appearance of the diagnosis PTSD was in the DSM-III. Since 
then, multiple revisions have been made, but the most extensive changes to the diagnosis are 
made in the last revision of the DSM, which led to the DSM 5.  
The biggest change to the PTSD diagnosis in the DSM 5 is the move out of the anxiety 
disorders chapter, into the new trauma- and stressor-related disorders chapter in the DSM 5. 
Disorders in this chapter are defined as the onset or worsening of symptoms following a 
traumatic event. The diagnosis PTSD requires exposure to an event that involved or held the 
threat of death, violence or serious injury, in one of the following ways: directly experiencing 
the event, witnessing the event, learning about details of an event that happened to a close 
family member or close friend or experiencing repeated or extreme exposure to aversive 
details of a traumatic event (criterion A). Exposure through media does not meet criterion A, 
unless it is work related. Patients have to experience symptoms of the following symptom 
clusters, for more than a month (criterion F): intrusion symptoms (criterion B), persistent 
avoidance of stimuli associated with the traumatic event (criterion C), negative alterations in 
cognitions and mood (criterion D) and alterations in arousal and reactivity (criterion E). The 
diagnosis requires the presence of a minimum of one criterion B, one criterion C, two 
criterion D and two criterion E symptoms. Criterion G states that there should be significant 
symptom related distress or functional impairment and criterion H excludes the presence of 
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PTSD when the disturbances are due to medication, substance use or other illness (Miller, 
Mark, Wolf, Erika, Keane, & Terence, 2014). 
Two PTSD subtypes were added to the DSM 5 (Friedman, 2013). Individuals who 
meet the PTSD criteria and also experience depersonalization and/or derealisation symptoms 
are diagnosed with the dissociative subtype. The addition of this subtype was based on 
multiple lines of research. Firstly, individuals with PTSD and dissociative symptoms show a 
different functional magnetic resonance imaging (fMRI)  pattern; these patients have 
excessive prefrontal cortical activity associated with reduced activity in the amygdale, which 
is a reversal of the fMRI pattern that is usually seen with PTSD patients (lanius, Brand, 
Vermetten, Frewen, & Spiegel, 2012). Furthermore, recent research showed that symptom 
severity, chronicity, functional impairment and suicidality were worse among patients who 
also experience dissociative symptoms (Stein et al., 2013). Finally, research indicates that the 
optimal treatment differed for individuals with dissociative symptoms (Lanius et al., 2012). 
The second subtype that was added to the DSM 5 is the preschool subtype, which has separate 
diagnostic criteria. Research indicated that the diagnostic criteria for preschool children 
should be more behaviourally anchored and developmental sensitive to detect PTSD in this 
age group (Sheeringa, Seanah, & Cohen, 2011). This led to the inclusion of the preschool 
subtype, for children ages six years and younger (Friedman, 2013).  
Another specification of PTSD in de DSM IV was ‘PTSD with delayed onset’. This 
specification has been slightly altered to ‘PTSD with delayed expression’, because most 
individuals with this trajectory do experience immediate symptoms but do not meet the 
diagnosis of full PTSD until some later time. Patients are diagnosed with PTSD with delayed 
expression when the diagnostic threshold is not reached until six months after the traumatic 
event (Friedman, Resick, Bryant, & Brwin, 2011). The distinction between acute and chronic 
PTSD has been eliminated in the DSM 5 (Friedman, 2013). 
 
1.2 Eye Movement Desensitisation Reprocessing  
Clinical psychologist Francine Shapiro developed EMDR in the 1980s (Logie, 2014). In this 
therapy, unprocessed traumatic experiences that cause ongoing psychological disturbance are 
identified and patients are asked to focus on a disturbing image of the traumatic event, while 
simultaneously carrying out an external task, such as bilateral eye movements. EMDR is an 
evidence-based treatment for PTSD. According to the NICE guidelines (2005), all patients 
with PTSD should be offered trauma focused cognitive behaviour therapy or EMDR 
treatment. 
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 The current theory about the working mechanism of EMDR concerns the use 
of a dual attention task. The recall of the traumatic event and the eye movements both use 
working memory capacity. Working memory capacity is limited and recalling a traumatic 
memory taxes the working memory resources because the memory is intense, vivid and 
emotionally charged. When a patient is simultaneously executing another task, there will be 
less resources available for the memory. As a consequence, there will be less memory 
resources for the vividness and emotionality of the memory and the memory will become less 
disturbing, vivid and emotionally charged (De Jongh, Ernst, Marques, & Hornsveld, 2013).  
Recently, a meta-analysis was performed on the results of 26 Randomized Controlled 
Trials (RCT’s) of EMDR treatment for PTSD, that were published between 1991 and 2013 
(Chen et al., 2014). The outcome of this meta-analysis confirmed that EMDR treatment 
significantly reduces PTSD symptoms and, furthermore, it also significantly reduces 
symptoms of depression and anxiety and subjective distress. Since EMDR also impacts other 
psychological symptoms and disorders, different protocols have been developed for a wide 
variety of disorders (Logie, 2014). A RCT investigated the effectiveness of EMDR for boys 
with conduct problems. This study found that the EMDR treatment led to large and significant 
reductions of memory-related distress and problem behaviours. Non-randomized studies 
found that EMDR can be an effective therapy for patients with a borderline personality 
disorder, generalized anxiety disorder, bulimia nervosa, phobia and pain management. Case 
studies revealed positive effects of EMDR on depression as primary diagnosis, but this has 
not yet been investigated with a RCT. EMDR treatment does significantly reduce depression 
symptoms when it occurs comorbidly with PTSD. EMDR can also be used to treat obsessive 
compulsive disorder (OCD). In four case studies OCD was successfully treated with EMDR 
and a RCT showed that EMDR is more effective than medication. Finally, a pilot study 
demonstrated that EMDR is an effective and safe therapy for the treatment of PTSD in 
patients with a psychotic disorder. The treatment also had a positive effect on auditory verbal 
hallucinations, delusions, anxiety symptoms, depression symptoms and self-esteem (Logie, 
2014). So the effectiveness of EMDR for PTSD is well established and there is also evidence 
that EMDR can have an effect on other psychological disorders.  
 
1.3 Trauma-Sensitive Yoga 
This pilot study of intensive EMDR treatment for PTSD is the first study in which patients 
receive EMDR sessions twice a day, which is a very intensive treatment format. Since there 
were concerns about the tolerability of such an intensive program, it was decided to 
6 
 
incorporate yoga in the treatment program. The last decade, there has been an increasing 
interest in the potential of yoga as a treatment for PTSD. Since yoga incorporates social 
interaction, physical activity and meditation, all of which are elements that are known to 
improve the course of PTSD,  it makes sense that researchers have started investigating its 
potential for treating PTSD (Wynn, 2015). Also, research has demonstrated that yoga 
practices can improve the ability of PTSD patients to tolerate unpleasant feelings (Jindani et 
al., 2015). Therefore, it has a great potential as an adjunctive treatment, especially with 
intensive treatment programs like the one that is evaluated in this pilot study.  
The practice of yoga consists of coordinated breathing, movement and meditation 
(Jeter, Slutsky, Sing, & Khalsa, 2015). Yoga is a varied practice and at this time, it is unclear 
which style of yoga is the best for patients with PTSD. The Trauma Centre at the Justice 
Resource Institute in Brookline, Massachusetts, developed trauma-sensitive yoga (TSY). This 
is a form of yoga that is customized to make it suitable for PTSD patients.  The following 
aspects require special consideration in TSY: the environment, exercises, teacher qualities, 
assists and language. Firstly, patients should feel safe in the environment in which the yoga is 
practiced. Also, the exercises in the yoga sessions should be offered in a trauma-sensitive 
way, which means that patients should be offered multiple options for relaxation and postures. 
Important teacher qualities are: being present, positive, engaged, welcoming, approachable, 
competent with the yoga material, open for feedback and willing to make changes when 
things are not working. Physical assists are dissuaded, especially during the first months of 
TSY, but verbal assists can be valuable. Verbal assists can show that a teacher attends to the 
patient in a nurturing way, while at the same time respecting the physical space of the patient. 
Language is the final aspect that needs consideration. In TSY it is not about getting patients to 
do something. Instead, it is about inviting patients to try something. This is done with 
invitatory language, in which patients are invited to do something but are not required or 
pushed to do it (Emerson, Sharma, Chaudhry, & Turner, 2009). 
Three studies investigated the effectiveness of TSY for PTSD. In the first pilot study, 
16 women were randomly assigned to either an eight weeks TSY intervention or to a 
dialectical behaviour therapy group intervention. Self-report inventories measuring the 
severity of the PTSD symptoms, positive and negative affect and body awareness were used 
to compare the effects of the interventions. The participants in the yoga intervention group 
showed improvements on al measurements and the reduction in frequency of the PTSD 
symptoms and the severity of hyperarousal symptoms was greater than with the participants in 
the dialectical behaviour therapy group. Due to the small sample size, the results were not 
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significant, but yoga does appear to have positive effects for PTSD patients (Emerson, 
Sharma, Chaudhry, & Turner, 2009). Another pilot study investigated the feasibility of thirty 
minutes yoga after each 12 weekly group therapy session (Clark et al., 2014).  A control 
group received typical psychotherapy. The efficacy of the yoga intervention could not be 
established, but the study did show that the yoga intervention can be administered without any 
adverse effects. Finally, a RCT investigated the effectiveness of TSY. In this study, 64 
woman with chronic treatment resistant PTSD were randomly assigned to either 10 weeks of 
yoga or supportive health education. The yoga intervention significantly reduced the PTSD 
symptoms, with effect sizes comparable to evidence-based psychotherapeutic treatments and 
well-studied psychopharmacologic treatment (Van der Kolk et al., 2014). The results of these 
studies are promising, but cannot be generalized, since there has been only one RCT in which 
the effectiveness of TSY was investigated.  
Given the fact that TSY was specifically developed for PTSD patients and the positive 
results concerning the feasibility and effectiveness of the intervention, this specific form of 
yoga was incorporated in the intensive EMDR treatment program. 
 
1.4 Research on intensive treatment formats for PTSD 
Psychological treatments for PTSD, such as EMDR, are usually delivered in weekly of 
biweekly sessions and it can take several months to treat the disorder. However, if this is the 
best format for treating PTSD can be questioned. Firstly, it can be a problem for patients who 
live far away from the treatment services and have to travel long distances (Stecker, Fortney, 
Hamilton, Sherbourne, & Ajzen, 2010). Secondly, PTSD has a large impact on the social and 
occupational functioning of patients (Bisson et al., 2007). Therefore it is desirable to make 
more rapid progress. Furthermore, it can be difficult for patients to commit to prolonged 
psychological treatment, which can lead to drop-out and non-compliance (Bisson et al., 2007).  
 Researchers have started to investigate the feasibility, acceptability and effectiveness 
of intensive brief psychological therapies for PTSD. A case study examined the effectiveness 
of intensive outpatient prolonged exposure for combat-related PTSD. After a period of two 
weeks, in which the patient received 10 full day outpatient sessions, she no longer met the 
diagnostic threshold for PTSD. This treatment result was maintained at the six months follow 
up (Blount, Cigrang, Foa, Ford, & Peterson, 2014). Hendriks, De Kleine, Van Rees, Bult en 
Van Minnen (2010) studied the feasibility of an brief intensive exposure programme for four 
PTSD patients with a history of childhood sexual abuse. Patients in this study experienced 
multiple (sexual) traumas during their childhood, had high comorbidity levels and high levels 
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of psychosocial stressors. The treatment programme consisted of individual sessions for five 
working days, with a mean of six hours of treatment a day and 24 of the 30 hours in total 
where dedicated to trauma processing. Patients stayed in a hotel during the night to limit 
interference of psychosocial stressors. The results of the treatment indicate substantially 
decrease of PTSD symptoms and the effect sizes were large. Moreover, patients showed no 
symptom worsening and none of the patients dropped out. Teng et al. (2015) examined the 
feasibility and effectiveness of an intensive weekend group treatment for veterans with a 
panic disorder and co-occurring PTSD. Patients received psycho education, cognitive 
restructuring and introspective exposure for six hours each day. All 10 patients completed the 
treatment program and the panic symptoms were significantly reduced at the end of the 
treatment, which was maintained at a seven month follow up. Also, a large effect size was 
observed for the reduction of PTSD symptoms. Ehlers et al. (2014) did a RCT of seven day 
intensive and standard weekly cognitive therapy and emotion-focused supportive therapy for 
chronic PTSD. Participants (n = 121) received seven days intensive cognitive therapy for 
PTSD, three months standard weekly cognitive therapy or three months weekly emotion-
focused supportive therapy or were placed on a fourteen week waiting list. Changes in PTSD 
symptoms and diagnosis were measured with the Clinician Administered PTSD Scale (CAPS) 
and a self-report questionnaire. Secondary outcome measures were disability, anxiety, 
depression and quality of life. Intensive cognitive therapy for PTSD led to a faster decrease of 
PTSD symptoms and comparable overall outcomes as standard cognitive therapy. For both 
intensive as standard cognitive therapy, effect sizes for improvement of PTSD symptoms and 
disability were very large and effect sizes for anxiety, depression and quality of life were 
large. Symptom deterioration ratings were low in both the intensive and standard cognitive 
therapy condition. Drop-out rates were the same in the intensive and standard format of 
cognitive therapy, as well as low. The results of this study suggest that intensive cognitive 
therapy is as effective as standard cognitive therapy, can achieve faster symptom reduction 
and is well tolerated. 
 The outcomes of the described studies of intensive therapies for PTSD are positive. 
The treatment programs were well tolerated and resulted in a (significant) reduction of PTSD 
symptoms. Intensive, brief treatment can even be as effective as standard therapy, with a 
faster symptom reduction. Since research has shown that intensive formats of other therapies 
for PTSD are well tolerated and effective, it makes sense to also examine the effectiveness of 
intensive EMDR treatment. 
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1.5 A pilot study of intensive EMDR 
A non-randomized, uncontrolled, evaluative pilot study will investigate the effectiveness of an 
intensive EMDR inpatient treatment program. The research will take place in the national 
treatment and expertise centre for psychological trauma in the Netherlands: ‘Stichting 
Centrum 45’. This paper will focus on the effectiveness of the intensive EMDR inpatient 
treatment program for reducing the PTSD symptoms and the effects of the treatment on 
psychological distress and comorbid disorders. The following research questions will be 
answered:  
Is an intensive, inpatient EMDR treatment program effective for PTSD? To answer this 
research question, the following hypotheses will be tested: 
1) Patients total score on the Clinician Administered PSTD Scale (CAPS-5) two weeks after 
the intensive EMDR treatment program is significantly lower than their total score on the 
CAPS-5 before the intensive EMDR treatment program.  
a) Patients score on the subscale re-experiencing of the CAPS-5 two weeks after the 
intensive EMDR treatment program is significantly lower than their score on the 
subscale re-experiencing of the CAPS-5 before the intensive EMDR treatment 
program. 
b) Patients score on the subscale avoidance of the CAPS-5 two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
avoidance of the CAPS-5 before the intensive EMDR treatment program. 
c) Patients score on the subscale negative cognitions and mood of the CAPS-5 two weeks 
after the intensive EMDR treatment program is significantly lower than their score on 
the subscale negative cognitions and mood of the CAPS-5 before the intensive EMDR 
treatment program. 
d) Patients score on the subscale arousal of the CAPS-5 two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
arousal of the CAPS-5 before the intensive EMDR treatment program. 
2) Patients total score on the PTSD Checklist for DSM-5 (PCL-5) after the last EMDR 
session is significantly lower than their total score on the PCL-5 before the intensive 
EMDR treatment program. 
a) Patients score on the subscale re-experiencing of the PCL-5 after the last EMDR 
session is significantly lower than their score on the subscale re-experiencing of the 
PCL-5 before the intensive EMDR treatment program. 
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b) Patients score on the subscale avoidance of the PCL-5 after the last EMDR session is 
significantly lower than their score on the subscale avoidance of the PCL-5 before the 
intensive EMDR treatment program. 
c) Patients score on the subscale negative cognitions and mood of the PCL-5 after the 
last EMDR session is significantly lower than their score on the subscale negative 
cognitions and mood of the PCL-5 before the intensive EMDR treatment program. 
d) Patients score on the subscale arousal of the PCL-5 after the last EMDR session is 
significantly lower than their score on the subscale arousal of the PCL-5 before the 
intensive EMDR treatment program. 
3) Patients total score on the PCL-5 two weeks after the intensive EMDR treatment program 
is significantly lower than their total score on the PCL-5 before the intensive EMDR 
treatment program. 
a) Patients score on the subscale re-experiencing of the PCL-5 two weeks after the 
intensive EMDR treatment program is significantly lower than their score on the 
subscale re-experiencing of the PCL-5 before the intensive EMDR treatment program. 
b) Patients score on the subscale avoidance of the PCL-5 two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
avoidance of the PCL-5 before the intensive EMDR treatment program. 
c) Patients score on the subscale negative cognitions and mood of the PCL-5 two weeks 
after the intensive EMDR treatment program is significantly lower than their score on 
the subscale negative cognitions and mood of the PCL-5 before the intensive EMDR 
treatment program. 
d) Patients score on the subscale arousal of the PCL-5 two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
arousal of the PCL-5 before the intensive EMDR treatment program. 
Is an intensive, inpatient EMDR treatment program effective for comorbid disorders? To 
answer this research question, the following hypothesis will be tested: 
4) Patients who were diagnosed with a comorbid disorder will no longer meet the diagnostic 
criteria for a comorbid disorder after the intensive EMDR treatment program, according to 
the Mini International Neuropsychiatric Interview (MINI).  
Does an intensive, inpatient EMDR treatment program result in a decrease of psychological 
distress? To answer this research question, the following hypotheses will be tested: 
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5) Patients score on the Global Severity Index (GSI) of the Brief Symptom Inventory (BSI) 
two weeks after the intensive EMDR treatment program is significantly lower than their 
score on the GSI of the BSI before the intensive EMDR treatment program. 
a) Patients score on the subscale somatisation of the BSI two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
somatisation before the intensive EMDR treatment program. 
b) Patients score on the subscale obsessive-compulsive of the BSI two weeks after the 
intensive EMDR treatment program is significantly lower than their score on the 
subscale obsessive-compulsive before the intensive EMDR treatment program. 
c) Patients score on the subscale interpersonal sensitivity of the BSI two weeks after the 
intensive EMDR treatment program is significantly lower than their score on the 
subscale interpersonal sensitivity before the intensive EMDR treatment program. 
d) Patients score on the subscale depression of the BSI two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
depression before the intensive EMDR treatment program. 
e) Patients score on the subscale anxiety of the BSI two weeks after the intensive EMDR 
treatment program is significantly lower than their score on the subscale anxiety 
before the intensive EMDR treatment program. 
f) Patients score on the subscale hostility of the BSI two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
hostility before the intensive EMDR treatment program. 
g) Patients score on the subscale phobic anxiety of the BSI two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
phobic anxiety before the intensive EMDR treatment program. 
h) Patients score on the subscale paranoid ideation of the BSI two weeks after the 
intensive EMDR treatment program is significantly lower than their score on the 
subscale paranoid ideation before the intensive EMDR treatment program. 
i) Patients score on the subscale psychoticism of the BSI two weeks after the intensive 
EMDR treatment program is significantly lower than their score on the subscale 
psychoticism before the intensive EMDR treatment program. 
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2 Method 
This chapter describes the method of the pilot study. Characteristics of the participants 
(paragraph 2.1), the research design (paragraph 2.2), the procedure of the study (paragraph 
2.3), the interviews and questionnaires that are used to test the hypotheses of this paper 
(paragraph 2.4) and the statistical analysis (paragraph 2.5) are described.  
 
2.1 Participants  
A sample of seven patients participated in this study. Patients of whom the intaker of Centrum 
45 judged as suitable for the intensive EMDR treatment, were referred to this pilot study. 
Participants were screened for PTSD with the Life Events Checklist for DSM-5 (LEC-5), 
CAPS-5 and the PCL-5. Also, the BSI was used to assess psychological distress. Furthermore, 
patients were assessed on the Mini International Neuropsychiatric (MINI) to investigate 
whether intensive EMDR treatment is also suitable for patients with comorbid disorders. 
Inclusion criteria were: patients are diagnosed with PTSD according to the CAPS-5, patients 
are motivated for brief inpatient treatment, patients have a relapse prevention plan and 
patients have a therapist for the follow-up treatment. Exclusion criteria were: non-Dutch 
speaking, acute suicidality, severe psychotic symptoms and severe substance dependency.  
 
2.2 Research design  
This study has a case series design. There was a baseline measurement before admission to 
the clinic. Participants were assessed on the Life Event Checklist for DSM-5 (LEC-5), CAPS-
5, Mini International Neuropsychiatric (MINI), BSI, and PCL-5.  
During the hospitalization, patients had to fill in a visual analogue scale (VAS) after every 
EMDR session, to monitor tolerability, suicidality and dissociation. On the first day and the 
last day of the hospitalization, patients were tested on the PCL-5. After the follow up session 
a week after the hospitalization, patients were assessed on the VAS and PCL-5. Finally, 
patients were tested one week after the follow up session on the CAPS-5, MINI, BSI, and 
PCL-5. In figure 1, the procedure of the pilot study, including the assessment time points, is 
graphically displayed.  
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 Figure 1. Graphic display of the procedure of the pilot study. 
Prior treatment
Treatment
Hospitalisation
Baseline assessment
Maximum a month before the start of the treatment:
-LEC-5
-CAPS-5
-MINI
-PCL-5
-BSI
Day 1
Psycho-
education 
EMDR
Assessment:
-PCL-5, -VAS
Follow-up session 6 or 7 days after the 
hospitalisation
EMDR
Assessment:
-VAS
-PCL-5
After treatment
Assessment
between 6 and 8 
days after the 
follow-up EMDR 
session:
-CAPS-5
-MINI
-PCL-5
-BSI
Referral to intensive EMDR treatment after the 
intake at Centrum 45
A maximum of 3 preparation sessions
Day 2 
EMDR
EMDR
Assessment:
-VAS, -VAS
Day 1
Psycho-
education 
EMDR
-PCL-5, -VAS
Day 1
Psycho-
education 
EMDR
-PCL-5, -VAS
Day 1
Psycho-
education 
EMDR
-PCL-5, -VAS
3
EMDR
EMDR
Assessment:
VAS, -VAS
4 
EMDR
EMDR
Assessment:
VAS, -VAS
5 
EMDR
EMDR
Assessment:
VAS, -VAS,
-PCL-5
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2.3 Procedure  
Prior to the inpatient treatment, patients had a maximum of three preparation sessions in 
which a treatment plan was jointly drawn up by therapist and patient, a relapse prevention 
plan was made and patients received psycho-education about PTSD, EMDR, stabilization 
techniques and the rationale behind the treatment program. Together with the therapist, 
patients selected three to five traumatic memories to be processed during the EMDR sessions 
and lastly, patients were shown the clinic of Centrum 45. On the first day of the 
hospitalization, patients received psycho-education about PTSD and EMDR and, together 
with their therapist, they discussed the treatment plan and the order of the traumatic memories 
to be processed. At midday, patients had their first EMDR session. The other four days of the 
hospitalization, patients had EMDR sessions twice a day. The duration of EMDR sessions 
was 90 minutes. Patients also received TSY for one hour every day and were encouraged to 
fill in their free time with going on walks and exercising. One week after the inpatient 
treatment, patients received a final follow-up EMDR session.   
 
2.4 Tests 
In order to answer the research questions of this study, a number of interviews and self-report 
questionnaires were used. The Life Event Checklist for DSM-5 (LEC-5) was used to assess 
exposure to traumatic events (paragraph 2.4.1). The CAPS-5 and the PCL-5 were used to 
answer the first research question: is an intensive, inpatient EMDR treatment program 
effective for PTSD? (paragraph 2.4.2 en paragraph 2.4.3). The MINI was used to answer the 
second research question: is an intensive, inpatient EMDR treatment program effective for 
comorbid disorders? (paragraph 2.4.4). The BSI was used to answer the third research 
question: Does an intensive, inpatient EMDR treatment program result in a decrease of 
psychological distress (paragraph 2.4.5). 
 
2.4.1 The LEC-5 
The LEC-5 assesses exposure to traumatic events. There are three formats in which the LEC-5 
can be administered: as a standard self-report to determine if a traumatic event occurred, as an 
extended self-report to identify the worst event and as an interview to determine if criterion A 
is met. It is recommended to administer the LEC-5 before the CAPS-5, to establish if criterion 
A is met. In this pilot study, the LEC-5 was administered at the baseline assessment as an 
interview before the CAPS-5. The LEC-5 consists of 17 items. The first 16 items represent 16 
events that can result in PTSD and the last item assesses any other stressful event that was not 
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yet assessed in the prior items. Possible responses to an item, for example a natural disaster, 
are: happened to me, witnessed it, learned about it, part of my job, not sure or no exposure to 
the event.  
The previous LEC for DSM-IV demonstrated good psychometric properties. Gray, 
Litz , Hsu and Lombardo (2004) describe two studies in which the psychometric properties of 
the LEC are investigated. The first study compared the LEC to the Traumatic Life Events 
Questionnaire (TLEQ), a questionnaire of which the psychometric quality is well established, 
in a college undergraduates sample (n = 108). With regard to the reliability of the LEC when 
it is used as a measure of direct trauma exposure, all item kappas were above .50 and only one 
item had a kappa lower than .40. The mean kappa was .61 and the retest correlation was r = 
.82. The low reliability that was found for some of the items is attributable to low base rates 
of those events. The reliability of the items is lower when all indirect exposure response 
options were included, but even then 12 of the 17 items achieved a kappa of .40 or higher. 
The total score correlation between the LEC and the TLEQ was r = .55. The correlation with 
related symptom measures (the modified PTSD symptom scale and the PTSD checklist) was 
similar for the LEC and the TLEQ, both having Pearson r  coefficients ranging from .34 and 
.48. In the second study that is described, the correlations between the LEC and measures of 
psychopathology that is associated with exposure to trauma were investigated in a clinical 
sample of combat veterans (n =131). This study found that the LEC was significantly related, 
in the predicted direction, to the PCL-M (r = -.43), the CAPS (r = -.39) and the Mississippi 
Scale (r = -.33). When the LEC was revised, two changes were made in the questionnaire: 
item 15 is now named  “sudden accidental deaths” instead of “sudden, unexpected death of 
someone close to you” and “part of my job” was added as possible response category. Since 
the difference between the LEC and the LEC-5 are minimal, the psychometric properties are 
expected to be the same (“Life Events Checklist for DSM-5 (LEC-5)”, n.d.). 
 
2.4.2 The CAPS-5 
The CAPS is the standard criterion measure for diagnosing and measuring the severity of 
PTSD (Pupo et al., 2011). In response to changes in diagnostic criteria of PTSD, the CAPS 
has been revised several times. In this study the CAPS-5 was used, which was developed in 
response to the publication of the DSM-5.  The CAPS-5 contains 30 items that are rated on a 
5-point likert-type scale, ranging from zero (absent) to four (extremely). It assesses the twenty 
DSM-5 PTSD symptoms and in addition to that, there are also questions about the onset and 
duration of symptoms, subjective distress, the effect of PTSD symptoms on social and 
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occupational functioning, response validity, overall PTSD severity, improvement of 
symptoms since a previous administration and dissociative symptoms. There are three 
versions of the CAPS-5: the past week version to assess PTSD symptoms over the past week, 
the past month version to make a current diagnosis of PTSD and the worst month version to 
make a lifetime PTSD diagnosis. In this pilot study, the past month version was used to assess 
the PTSD symptoms before the intensive treatment program and to make a current PTSD 
diagnosis and the past week version was used to assess the PTSD symptoms the week after 
the intensive treatment program (“Clinically-Administered PTSD Scale for DSM-5”, n.d.). 
Weathers, Keane and Davidson (2001) reviewed the first ten years of research that has 
been done on the psychometric properties of the CAPS. Researchers have investigated the 
psychometric properties of the CAPS across a wide variety of trauma populations: combat 
veterans, resistance veterans, concentration camp survivors, older combat veterans, Vietnam 
veterans, military personnel with mixed military and civilian trauma exposure and motor 
vehicle accident victims. Weathers et al. (2001) found that the CAPS has excellent reliability, 
with interrater reliability scores of .90 or higher and test-retest reliability scores between .86 
and 1.00. Internal consistency is high, with alphas between .80 and .90. The found convergent 
validity of the CAPS is also good in these studies, with correlations at the .70 level and above. 
Research on discriminant validity is difficult, because depression and anxiety conceptually 
overlap with PTSD. Weathers et al. (1999) found correlations between CAPS total severity 
and measures of depression and anxiety in the range of .61 and .76, but when controlling for 
the effects of nonspecific distress, the correlations are in the range of .37 and .55. When 
measures of antisocial personality disorder were used, which is a construct that is 
conceptually unrelated to PTSD, weaker correlations with the CAPS total severity are found 
(between .14 and .33) and after controlling for the effects of nonspecific distress, the 
correlations are almost zero (between -.05 and .02). So there is some evidence for 
discriminant validity, but more research is needed. The diagnostic utility of the CAPS is high, 
with sensitivities and specificities above .80 and kappas above .70. The results of these studies 
indicate that the psychometric properties of the CAPS are adequate. 
  
2.4.3 The PCL-5 
The PCL is the most commonly used self-report questionnaire for PTSD. More than twenty 
validation studies in a wide range of populations found that the reliability and validity of the 
self-report questionnaire is generally good (McDonald & Calhoun, 2010). When it is used in 
combination with a diagnostic interview, the PCL is an effective method to identify PTSD 
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(Schlenger, Jordan, Caddell, Ebert, & Fairbank, 20014). The PCL has been revised several 
times in response to changes in diagnostic criteria of PTSD. In this pilot study the PCL-5 was 
used, which was developed in response to the publication of the DSM-5.  The PCL-5 contains 
twenty items that correspond with the twenty DSM-5 PTSD symptoms. Respondents have to 
rate the degree in which they experienced PTSD symptoms in the past month on a 5-point 
likert scale, ranging from one (not at all) to five (extremely). There are multiple ways to 
interpret PCL-5 scores of patients. Firstly, a total symptom severity score can be obtained and 
a cut off point of 33 can be used. Also, PTSD can be diagnosed. Each item that is rated as 2 or 
higher is treated as a symptom endorsed and a PTSD diagnosis can be made when the 
diagnostic rule of the DSM-5 is met. Finally, the PCL-5 can be used to monitor patient 
progress: for the PCL for the DSM-IV a change of five points was the minimum threshold to 
determine that a patient has responded to treatment and a change of ten points was the 
minimum threshold to determine that the improvement is clinically significant. It is expected 
that the change scores for the PCL-5 will be in the similar range (“PTSD checklist for DSM-5 
(PCL-5)”, n.d.).  
Since the PCL-5 is recently developed, there has not been much research done on the 
psychometric properties of the diagnostic instrument. Two studies investigated the 
psychometric properties of the PCL-5 in a trauma-exposed college student population 
(Blevins, Weathers, Davis, Witte, & Domino, 2015). Study one (N = 278) found strong 
internal consistency (ɑ = .94), test-retest reliability (r = .82), convergent validity (rs = .74 to 
.85) and discriminant validity (rs = .31 to .60). Study two (N = 558) also found high internal 
consistency (ɑ = .95) and demonstrated similarly strong reliability and validity as the 
researchers found in study one. The results of these studies indicate that the psychometric 
properties of the PCL-5 are adequate (Blevins et al., 2015). 
  
2.4.4 The MINI 
The MINI is a short diagnostic structured interview that is used to diagnose the DSM mental 
disorders. The reliability and validity of the MINI are well established (Lecrubier et al., 1997; 
Sheehan et al., 1997). Good validity and reliability was demonstrated in a study that 
investigated the validity and reliability of the MINI according to the Composite International 
Diagnostic Interview (CIDI) (Lecrubier et al., 1997). The specificity of the MINI was 
adequate, ranging from .72 to .97. The lowest sensitivity was found for simple phobia and 
agoraphobia (.46 and .59) and the highest sensitivity was found for depressive episode (.94). 
Inter-rater reliability was good (ranging from .88 and 1.00) and test-retest reliability was also 
18 
 
high (kappa coefficients between .76 and .93). A study that investigated the validity and 
reliability of the MINI according to the Structured Clinical Interview for DSM-III-R (SCID) 
(Sheehan et al., 1997) also found high specificity (between .86 and 1.00). The lowest 
sensitivity was found for current drug dependence and obsessive compulsive disorder (.45 and 
.62) and the highest sensitivity was found for major depressive disorder (.96). Excellent inter-
rater reliability was found, with kappa values ranging from .81 to 1.00. Test-retest reliability 
was also good for most diagnoses: sixteen out of 23 diagnoses had a test-retest reliability 
above .70 and only two diagnoses (current mania and lifetime simple phobia) had a test-retest 
reliability lower than .60. Since the MINI for the DSM-5 is not yet available, the MINI Dutch 
Version 5.0.0  for the DSM IV was used in this pilot study.  
  
2.4.5 The BSI 
The BSI is a shortened version of the Symptom Checklist 90-R. It is a self-report 
measurement of the subjective burden of having a mental illness. Respondents have to rate the 
intensity of distress that they have experienced during the past seven days on a 5-point Likert 
scale, ranging from zero (not at all) to four (extremely). The BSI measures nine primary 
symptom constructs: somatization, obsessive-compulsive, interpersonal sensitivity, 
depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism. The BSI 
also has three global indices of distress: the GSI score embodies the information about the 
number and the intensity of the symptoms, the Positive Symptom Distress Index (PSDI) is a 
measurement of the intensity of the symptoms and the Positive Symptom Total (PST) is a 
measurement of the number of symptoms (Derogatis & Melisaratos, 1983). In this pilot study, 
patients score on the GSI and the subscales after the treatment were compared to their score 
on the GSI and the subscales prior the treatment.  
Studies investigating the psychometric properties of the BSI have found that it has 
good reliability and validity (Derogatis, 1975; Boulet & Boss, 1991). The internal consistency 
is high. The lowest found alpha is for the subscale psychoticism (ɑ = .71)  and the highest 
found alpha is for the GSI score(ɑ = .96). Test-retest reliability is also good, ranging from .71 
(for the somatisation subscale) to .90 (for the GSI score). Convergent validity for the BSI is 
high (rs = .72 to .82). The value of the depression subscale to detect a depressive disorder is 
acceptable (sensitivity = .80 and specificity = .72). The value of the phobic anxiety subscale, 
somatisation subscale and anxiety subscale to detect any anxiety disorder is somewhat lower, 
with a sensitivity of .67 and a specificity of .72 for the phobic anxiety subscale, a sensitivity 
of .67 and a specificity of .65 for the somatisation subscale and a sensitivity of .66 and a 
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specificity of .64 for the anxiety subscale. The sensitivity of the phobic anxiety subscale to 
detect a panic disorder with agoraphobia is .73 and its specificity is .64. Finally, the sensitivity 
of the interpersonal sensitivity subscale to detect social phobia is .67 and its specificity is .61. 
The Dutch version of the BSI also has sufficient reliability and validity and De Beurs & 
Zitman (2006) concluded that it is an excellent instrument to screen for psychopathology. 
  
2.5 Statistical analysis 
SPSS version 21 was used to analyze the data. Descriptive statistics were used to describe the 
demographic characteristics of the sample. Paired within sample t-tests for means were 
performed to test the hypotheses that patients total score on the CAPS-5 and their score on the 
subscales two weeks after the intensive EMDR treatment program is significantly lower than 
their total score on the CAPS-5 and their score on the subscales before the intensive EMDR 
treatment program. Paired within sample t-tests for means were also performed to test the 
hypotheses that patients score on the GSI of the BSI and the subscales of the BSI two weeks 
after the intensive EMDR treatment program is significantly lower than their score on the GSI 
of the BSI and the subscales of the BSI before the intensive EMDR treatment program. The 
assumptions for a paired within sample t-test are: the data that is measured is at least at the 
interval level and the data is normally distributed. The assumption that the data is measured at 
least at interval level is met. The assumption of normality was tested with a Shapiro Wilk test, 
which is a good test for normality with small sample sizes. Effect sizes were determined with 
Cohens d.  
Repeated measures ANOVA were performed to test the hypotheses that patients total score on 
the PCL-5 and their score on the subscales of the PCL-5 after the last EMDR session will be 
significantly lower than their total score on the PCL-5 and their score on the subscales of the 
PCL-5 before the intensive EMDR treatment program. Repeated measures ANOVA were also 
performed to test the hypotheses that patients total score on the PCL-5 and their score on the 
subscales of the PCL-5 two weeks after the intensive EMDR treatment program will be 
significantly lower than their total score on the PCL-5 and their score on the subscales of the 
PCL-5 before the intensive EMDR treatment program. Simple contrasts were used to compare 
patients score on the PCL-5 after the last EMDR session and two weeks after the treatment 
program with their score on the PCL-5 pre-treatment. The assumptions for a repeated 
measures ANOVA are: the data is at least at interval level, the data is normally distributed and 
the variances of the differences between all combinations of related groups (levels) are equel 
(the assumption of spericity). The assumption that the data is measured at least at interval 
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level is met. The assumption of normality was tested with a Shapiro Wilk test. The 
assumption of sphericity was tested with the Mauchly’s test. Effect sizes were determined 
with partial eta squared.  
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3 Results  
This chapter describes the results of this pilot study. Firstly, the characteristics of the 
participants will be presented in paragraph 3.1. Paragraph 3.2 presents the outcomes of the 
testing of hypotheses one, two and three, in order to answer the first research question: is an 
intensive, inpatient EMDR treatment program effective for PTSD? After that, the outcomes of 
the testing of hypothesis four are described in paragraph 3.3 to answer the second research 
question: is an intensive, inpatient EMDR treatment program effective for comorbid 
disorders. Finally, the results of the testing of hypothesis five are presented in paragraph 3.4 
to answer the last research question: does an intensive, inpatient EMDR treatment program 
result in a decrease of psychological distress? 
 
3.1 Sample characteristics   
Participants in this study were patients with PTSD and one or more comorbid disorders. 
Characteristics of the patients of the sample and the experienced traumatic event(s) are 
presented in table 1.  
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Table 1 shows that the mean age of the patients was 46,86 with a standard deviation of 10,75. 
The mean number of years after the most significant traumatic event was 18,71 with a 
standard deviation of 14,60.  The sample was comprised of five men and two women. Of the 
seven patients, four patients had a history of other trauma. The passed time since the most 
Table 1
Sample and trauma characteristics 
Characteristics n  = 7
Min Max M Mdn SD
Age 32 59 46,86 50 10,75
Number of years after the most 1 39 18,71 20 14,60
significant traumatic event
N %
Sex
     Male 5 71,4
     Female 2 28,6
History of other trauma
     Yes 4 57
     No 3 43
Time since most significant
traumatic event
     < 5 years 1 14,3
     5-15 years 2 28,6
     15-25 years 2 28,6
     > 25 years 2 28,6
PTSD with delayed expression
     Yes 5 71,4
     No 2 28,6
Dissociative subtype
     Yes 1 14,3
     No 6 85,7
Comorbidity
     Depressive disorder 7 100
     Anxiety disorder 2 29
     History of substance 1 14
     dependence
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significant traumatic event was variable, with a range from one year to 39 years. Five patients 
were diagnosed with PTSD with delayed expression and one patient was diagnosed with the 
dissociative subtype. All patients had a comorbid depressive disorder and two patients also 
had a panic disorder with agoraphobia. One patient was diagnosed with alcohol dependence in 
early remission.  
Six patients completed the treatment program, while one patient dropped out after the 
first day of the hospitalisation. Furthermore, one patient did not attend to the fifth EMDR 
treatment session, but this patient did completed the rest of the treatment program. The patient 
that dropped out had decided to postpone the treatment of his PTSD because he found it more 
important to work on family related problems first. This patient was diagnosed with PTSD 
with delayed expression and a recurrent depression. Due to practical problems, the patient was 
not assessed on the CAPS-5 and the MINI post-treatment and was not tested on the PCL-5 at 
day five of the hospitalisation and after the follow up EMDR session.  
 
3.2 Is an intensive, inpatient EMDR treatment program effective for PTSD?  
In order to answer the first research question ‘is an intensive, inpatient EMDR treatment 
program effective for PTSD’, hypotheses one, two and three were tested. In paragraph 3.2.1, 
the results of the testing of hypothesis one, patients total score on the CAPS-5 two weeks after 
the intensive EMDR treatment program is significantly lower than their total score on the 
CAPS-5 before the intensive EMDR treatment program, are outlined. In paragraph 3.2.2, the 
results of the testing of hypotheses two and three, patients total score on the PCL-5 after the 
last EMDR session and patients total score on the PCL-5 two weeks after the intensive 
treatment are significantly lower than their total score on the PCL-5 before the intensive 
EMDR treatment program, are described.  
 
3.2.1 Is an intensive, inpatient EMDR treatment program effective for PTSD, according 
to the CAPS-5? 
The first hypothesis stated that patients total score on the CAPS-5 two weeks after the 
intensive EMDR treatment program will be significantly lower than their total score on the 
CAPS-5 before the intensive EMDR treatment program. This hypothesis also contained four 
sub-hypotheses that state that patients score on the subscales of the CAPS-5 will be 
significantly lower than their scores on the subscales of the CAPS-5 before the intensive 
EMDR treatment program. The hypotheses were tested with a paired within samples t-test. 
The assumption that the data is at least at interval level was met. The assumption of normality 
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was tested with a Shapiro Wilk test. A Shapiro Wilk test showed that the data was normally 
distributed for the total score on the CAPS-5 (w(6) = .894, p = .341), the subscale re-
experiencing (w(6) = .935, p = .620), the subscale avoidance (w(6) = .916, p = .480), the 
subscale negative cognitions and mood (w(6) = .925, p = .541) and the subscale arousal (w(6) 
= .930, p = .582).  
In table 2 the mean scores of the patients on the CAPS-5 pre- and post-treatment are 
presented. 
 
Table 2 shows that a paired within sample t-test indicated that patients total score on the 
CAPS-5 post-treatment (M = 18, SD = 10,50) was significantly lower than their total score on 
the CAPS-5 pre-treatment (M = 39,67, SD = 6,28), t(5) = 4,030, p = .005, d = 1.65. On the 
subscale re-experiencing, patients score post-treatment (M = 3, SD = 3,29) was significantly 
lower than their score on the subscale pre-treatment (M = 11,17, SD = 2,14), t(5) = 5,171, p = 
.002, d = 2.11. The score of the patients post-treatment on the subscale avoidance (M = 1,33, 
SD =1,75) was also significantly lower than their score on the subscale pre-treatment (M =4, 
SD = 1,26), t(5) = 4,000, p = .005, d = 1.63. Patients score on the subscale negative cognitions 
and mood was post-treatment (M = 6,83, SD = 3,92) significantly lower than their score on 
the subscale pre-treatment (M = 13, SD = 4,2), t(5) = 2,060, p = .047, d =0.84. Finally, 
patients score on the subscale arousal post-treatment (M = 6,83, SD =3,06) was significantly 
lower than their score on the subscale pre-treatment (M = 11,5, SD = 2,81), t(5) = 3,715, p = 
.007, d =1.52. 
Of the six patients that completed the program, four patients did not meet the 
diagnostic criteria for PTSD anymore at the end of the treatment. This includes the patient 
that was diagnosed with the dissociative subtype. Five patients were diagnosed with PTSD 
with delayed expression and two patients were diagnosed with PTSD without delayed 
expression. Three of the patients that were diagnosed with PTSD with delayed expression and 
Table 2
Comparison of the mean scores of the patients on the CAPS pre- and post-treatment
Pre-treatment (n  = 6) Post-treatment (n  = 6)
CAPS M SD M SD t -waarde df
Total score 39,67 6,28 18,00 10,50 4,030** 5
Re-experiencing 11,17 2,14 3,00 3,29 5,171** 5
Avoidance 4,00 1,26 1,33 1,75 4,000** 5
Negative cognitions and mood 13,00 4,20 6,83 3,92 2,060* 5
Arousal 11,50 2,81 6,83 3,06 3,715** 5
Note. * p  < .05, ** p  < .01, *** p  < .001,  one-tailed. CAPS = Clinician Administered PTSD Scale.
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one of the patients that was diagnosed with PTSD without delayed expression did not meet 
the diagnostic criteria for PTSD anymore.  
 
3.2.2 Is an intensive, inpatient EMDR treatment program effective for PTSD, according 
to the PCL-5? 
Hypothesis two stated that patients score on the PCL-5 after the last EMDR session will be 
significantly lower than their score on the PCL-5 before the intensive EMDR treatment 
program. This hypothesis also contained four sub-hypotheses that state that patients score on 
the subscales of the PCL-5 after the last EMDR session will be significantly lower than their 
score on the subscales of the PCL-5 before the intensive EMDR treatment program. The 
hypotheses were tested with a repeated measures ANOVA. The assumption that the data is at 
least at interval level was met. The assumption of normality was tested with a Shapiro Wilk 
test. A Shapiro Wilk test showed that the data was normally distributed for the total score on 
the PCL-5 (w(7) = .835, p = .117), the subscale re-experiencing (w(7) = .868, p = .220), the 
subscale avoidance (w(7) = .866, p = .212), the subscale negative cognitions and mood (w(7) 
= .959, p = .815), and the subscale arousal (w(7) = .996, p = .999). Hypothesis three stated 
that patients score on the PCL-5 two weeks after the intensive EMDR treatment program is 
significantly lower than their score on the PCL-5 before the intensive EMDR treatment 
program. This hypothesis also contained four sub-hypotheses that state that patients score on 
the subscales of the PCL-5 two weeks after the intensive EMDR treatment will be 
significantly lower than their scores on the subscales of the PCL-5 before the intensive 
EMDR treatment program. The hypotheses were tested with a repeated measures ANOVA. 
The assumption that the data is at least at interval level was met. The assumption of normality 
was tested with a Shapiro Wilk test. A Shapiro Wilk test showed that the data was normally 
distributed for the total score on the PCL-5 (w(7) = .931, p = .556), the subscale re-
experiencing (w(7) = .825, p = .071), the subscale avoidance (w(7) = .952, p = .744), the 
subscale negative cognitions and mood (w(7) = .965, p = .858), and the subscale arousal (w(7) 
= .961, p = .828). The assumption of sphericity was tested with the Mauchly’s test. The 
Mauchly’s test indicated that the assumption of sphericity was not violated for the total score 
on the PCL-5 (X2 (9) = 4,760, p > .05), the subscale re-experiencing (X2 (9) = 10,589, p > 
.05), the subscale avoidance (X2 (9) = 3,705, p > .05), the subscale negative cognitions and 
mood (X2 (9) = 9,599, p > .05) and the subscale arousal (X2 (9) =17,681, p > .05).  
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In table 2 the mean scores of the patients on the PCL-5 pre-treatment (T1), at hospitalisation 
day one (T2), at hospitalisation day 5 (T3), after the follow-up EMDR session (T4) and two 
weeks  after the intensive treatment program (T5) are presented. 
 
Table 3 shows that a repeated measures ANOVA indicated that patients total score on the 
PCL-5 differed significantly across time, F(4, 20) = 3.943, p = .016, n = .818. Simple 
contrasts revealed that patients total score after the follow-up EMDR session was not 
significantly different from their total score pre-treatment, F(1, 5) = 1,741, p = .244, and that 
patients total score two weeks  after the treatment program was not significantly different 
from their total score pre-treatment, F(1, 5) = 5,233, p = .071.  A significant difference would 
have been found when the study aimed to compare the score of the patients to their total score 
on treatment day one: the total score of the patients after the follow-up EMDR session was 
significantly lower than their total score on treatment day one, F(1,5) = 8,127, p = .036, and 
their total score two weeks  after the treatment program was also significantly lower than their 
total score on treatment day one, F(1, 5) = 17,912, p = .008. On the subscale re-experiencing, 
patients score also differed significantly across time, F(4, 20) = 3,738, p = .02, n = .839. 
Simple contrasts revealed that patients score after the follow-up EMDR session was not 
significantly different from their score pre-treatment, F(1, 5) = 1,052, p = .352, and that 
patients score two weeks  after the treatment program was not significantly different from 
their score pre-treatment, F(1, 5) = 4,151, p = .097. A significant difference would have been 
found when the study aimed to compare the score of the patients to their score on treatment 
Table 3
Comparison of the mean scores of the patients on the PCL-5
(n  = 6) T1 T2 T3 T4 T5
M M M M M
PCL-5 (SD ) (SD ) (SD ) (SD ) (SD ) F -value df
Total score 45,83 50,67 42,67 36,50 30,83 3,943* 4
(12,86) (13,95) (16,95) (19,87) (20,70)
Re-experiencing 11,17 12,67 11,83 8,33 6,33 3,738* 4
(3,06) (3,61) (3,60) (5,79) (5,57)
Avoidance 5,17 4,83 3,33 3,50 2,83 3,489* 4
(1,72) (2,56) (2,94) (2,17) (2,56)
Negative cognitions 14,50 17,17 15,83 13,50 11,67 1,992 4
and mood (6,66) (6,46) (5,27) (6,77) (7,34)
Arousal 15,00 16 11,67 11,17 10,00 4,622** 4
(4,24) (4,43) (6,22) (5,91) (5,87)
Note. * p  < .05, ** p  < .01, *** p  < .001. PCL-5 = PTSD Checklist for DSM-5. T1 = pre-treatment, 
T2 = hospitalisation day 1, T3 = hospitalisation day 5, T4 = follow -up EMDR session, T5 = two weeks after the 
intensive treatment program.
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day one: the score of the patients two weeks  after the treatment program was significantly 
lower than their score on treatment day one, F(1,5) = 8,280, p = .035. Patients score on the 
subscale avoidance also differed significantly across time, F(4, 20) =3,498, p = .025, n = .844. 
Simple contrasts revealed that patients score after the follow-up EMDR session was 
significantly different from their score pre-treatment, F(1, 5) = 7,353, p = .042, and that 
patients score two weeks  after the treatment program was significantly different from their 
score pre-treatment, F(1, 5) = 14,412, p = .013.  On the subscale negative cognitions and 
mood, patients score did not differ significantly across time, F(4, 20) = 1,992, p = .135. 
Finally, the score of the patients on the subscale arousal differed significantly across time, 
F(4, 20) = 4.622, p = .008, n = .986. Simple contrasts revealed that patients score after the 
follow-up EMDR session was not significantly different from their score pre-treatment, F(1, 
5) = 4,205, p = .096, but that patients score two weeks  after the treatment program was 
significantly different from their score pre-treatment, F(1, 5) = 14,423, p = .013.     
The PCL-5 can be used to monitor patient progress. As mentioned in the ‘Method’ 
section, a change of five points is the minimum threshold to determine that a patient has 
responded to treatment and a change of ten points is the minimum threshold to determine that 
the improvement is clinically significant (“PTSD checklist for DSM-5 (PCL-5)”, n.d.). For 
three patients, the change on the PCL-5 was clinically significant at the assessment after the 
last EMDR session. A fourth patient had reached this threshold at the assessment two weeks 
after the treatment program.  
 
3.3 Is an intensive, inpatient EMDR treatment program effective for comorbid 
disorders?  
The second research question was: is an intensive, inpatient EMDR treatment program 
effective for comorbid disorders? To answer this research question, the following hypothesis 
was tested: patients who were diagnosed with a comorbid disorder will no longer meet the 
diagnostic criteria for a comorbid disorder after the intensive EMDR treatment program, 
according to the MINI. The outcomes of the assessment on the MINI pre- and post treatment 
are presented in table 4.  
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Table 4 shows that all seven patients had a depressive disorder on the assessment on the MINI 
pre-treatment. Two patients had a mild depressive disorder at the start of the treatment. One of 
these patients remained mildly depressed and the other patient was classified as having a 
depressive episode in early remission at the end of the treatment. One patient was diagnosed 
with a moderate depressive episode pre-treatment. This patient did not meet the diagnostic 
criteria anymore for a depressive disorder at the end of the treatment. One patient was 
diagnosed with a depressive episode in early remission at the assessment pre-treatment as well 
as post-treatment. Two patients were diagnosed with a recurrent depression and were 
currently depressed pre-treatment. One of these patients still met the diagnosis recurrent 
depression and the other patient dropped out of the study. Finally, one patient was diagnosed 
with a chronic depression at the assessment pre-treatment as well as post-treatment. Two 
patients were also diagnosed with a panic disorder with agoraphobia at the start of the 
treatment. Post-treatment, one of these patients did not meet the diagnostic criteria for this 
anxiety disorder anymore. Two patients had a history of alcohol dependence. The patient that 
was diagnosed with alcohol dependence in early remission, still met the diagnostic criteria for 
this disorder post-treatment. The other patient had subclinical alcohol dependence pre-
treatment, but did not meet the diagnostic criteria for an alcohol dependence disorder anymore 
at the end of the treatment.   
 
Table 4
Comparison of the outcomes on the MINI pre- and post-treatment
Pre-treatment (n  = 7) Post-treatment (n  = 6)
MINI N % N %
Depressive disorder
     Mild depressive episode 2 28,6 1 14,3
     Moderate depressive episode 1 14,3 0 0,0
     Depressive episode in early remission 1 14,3 2 28,6
     Recurrent depression 2 28,6 1 14,3
     Chronic depression 1 14,3 1 14,3
Anxiety disorder
     Panic disorder with agoraphobia 2 28,6 1 14,3
History of substance
dependence
     Subclinical alcohol dependence 1 14,3 0 0,0
     Alcohol dependence in early remission 1 14,3 1 14,3
Note. MINI = Mini International Neuropsychiatric Interview.
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3.4 Does an intensive, inpatient EMDR treatment program result in a decrease of 
psychological distress? 
In order to answer the third research question ‘does an intensive, inpatient EMDR treatment 
program result in a decrease of psychological distress?’, hypothesis five was tested. This 
hypothesis stated that patients GSI score on the BSI two weeks after the intensive EMDR 
treatment after the intensive EMDR treatment program will be significantly lower than their 
GSI score on the BSI before the intensive EMDR treatment program. This hypothesis also 
contained nine sub-hypotheses that state that patients score on the subscales of the BSI two 
weeks after the intensive EMDR treatment after the intensive EMDR treatment program will 
be significantly lower than their score on the subscales of the BSI before the intensive EMDR 
treatment program. The hypotheses were tested with a paired within samples t-test. The 
assumption that the data is at least at interval level was met. The assumption of normality was 
tested with a Shapiro Wilk test. A Shapiro Wilk test showed that the data was normally 
distributed for the difference between the total score on the BSI (w(7) = .900, p = .328), the 
subscale somatisation (w(7) = .918, p = .451), the subscale obsessive-compulsive (w(7) = 
.853, p = .131), the subscale interpersonal sensitivity (w(7) = .952, p = .744), the subscale 
depression (w(7) = .960, p = .815), the subscale anxiety (w(7) = .875, p = .207), the subscale 
hostility (w(7) = .846, p = .112), the subscale phobic anxiety (w(7) = .863, p = .160), the 
subscale paranoid ideation (w(7) = .886, p = .255) and the subscale psychoticism (w(7) = .914, 
p = .424). In table 5, the mean scores of the patients on the BSI pre- and post-treatment are 
presented. 
 
Table 5
Comparison of the mean scores of the patients on the BSI pre- and post-treatment
Pre-treatment (n  = 7) Post-treatment (n  = 7)
BSI M SD M SD t -waarde df
GSI score 1,72 0,73 1,22 0,90 2,072* 6
Somatisation 1,35 0,64 0,90 0,67 1,526 6
Obsessive-compulsive 2,21 1,15 1,50 1,31 1,73 6
Interpersonal sensitivity 1,50 0,69 1,14 1,01 1,433 6
Depression 1,98 0,98 1,62 1,30 0,664 6
Anxiety 1,93 0,85 1,19 1,04 3,028* 6
Hostility 1,74 1,12 0,91 1,07 2,848* 6
Phobic anxiety 1,60 0,97 1,29 1,16 1,256 6
Paranoid ideation 1,37 1,07 1,14 1,02 1,22 6
Psychoticism 1,63 0,88 1,17 0,91 2,248* 6
Note. * p  < .05, ** p  < .01, *** p  < .001,  one-tailed. BSI = Brief Symptom Inventory, GSI = Global Severity Index.
30 
 
Table 5 shows that a paired within sample t-test indicated that patients GSI score on the BSI 
post-treatment (M = 1,22, SD = 0,90) was significantly lower than their GSI score on the BSI 
pre-treatment (M = 1,72, SD = 0,73), t(6) = 2,072, p = .042. The mean score of the patients 
post-treatment was lower than the mean score of the patients pre-treatment on all the 
subscales of the BSI, but this difference was not significant on the subscales somatisation, 
obsessive-compulsive, interpersonal sensitivity, depression, phobic anxiety and paranoid 
ideation. However, patients score on the subscale anxiety post-treatment (M = 1,19, SD = 
1,04) was significantly lower than their score on the subscale pre-treatment (M = 1,93, SD = 
0,85), t(6) = 3,028, p = .012, d = 1.14. On the subscale hostility, patients score post-treatment 
(M = 0,91, SD = 1,07) was also significantly lower than their score on the subscale pre-
treatment (M = 1,74, SD = 1,12), t(6) = 2,848, p = 0,15, d = 1.08. Finally, patients score on the 
subscale psychoticism post-treatment (M = 1,17, SD = 0,91) was significantly lower than their 
score on the subscale pre-treatment (M = 1,63, SD = 0,88), t(6) = 2,248, p = .033, d =0.85. 
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4 Discussion  
This pilot study investigated the effectiveness of an intensive EMDR inpatient treatment 
program. Firstly, the outcomes of the study are interpreted in paragraph 4.1. After that, the 
results of this study are evaluated against the outcomes of earlier studies in paragraph 4.2. The 
limitations of this study are described in paragraph 4.3. The chapter concludes with a 
summary and recommendations for a next study (paragraph 4.4).  
 
4.1 Outcomes of the study 
In order to answer the first research question ‘is an intensive, inpatient EMDR treatment 
program effective for PTSD?’, patients score on the CAPS-5 post-treatment was compared to 
their score on the CAPS-5 pre-treatment. The results of this study show that the patients in 
this study experience significantly less overall PTSD symptoms two weeks after the intensive 
EMDR treatment, with large effect sizes, and that this is also the case for the separate 
symptom categories; patients experience significantly less re-experiencing, avoidance, 
negative cognitions and mood and arousal symptoms. Also, of the six patients that completed 
the treatment program, four patients do not meet the diagnostic criteria for PTSD anymore, 
according to the assessment with the CAPS-5. This includes the patient that was diagnosed 
with the dissociative subtype and also met the diagnostic criteria for the delayed expression 
subtype, two other patients that were diagnosed with PTSD with delayed expression and one 
patient that was diagnosed with PTSD without delayed expression. This implies that an 
intensive EMDR treatment program can be suitable for different forms of PTSD.  
Next to a clinical interview, PTSD symptoms were also assessed with a self-report 
questionnaire, the PCL-5, which was administered five times during the study. The results of 
the study show that, compared to the baseline measurement, the patients report significantly 
less avoidance and arousal symptoms two weeks after the treatment program, with large effect 
sizes. They also experience less overall PTSD symptoms, re-experiencing symptoms and 
negative cognitions and mood symptoms after the treatment program, but, compared to the 
baseline measurement, this difference is not significant. However, the patients do report 
significantly less overall PTSD symptoms and re-experiencing symptoms compared to 
treatment day one. If the PCL-5 is used to monitor patient progress, a change of ten points is 
the minimum threshold to determine that the improvement is clinically significant (“PTSD 
checklist for DSM-5 (PCL-5)”, n.d.). For three of the six patients that completed the program, 
the change on the PCL-5 was clinically significant at the assessment after the last EMDR 
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session. A fourth patient had reached this threshold at the assessment two weeks after the 
treatment program. These results suggest that patients themselves experience significantly less 
avoidance and arousal symptoms after an intensive EMDR treatment program and that the 
treatment can lead to a clinically significant improvement.  
In order to answer the second research question ‘is an intensive, inpatient EMDR 
treatment program effective for comorbid disorders?’, patients were assessed on the MINI 
pre-treatment and two weeks after the treatment program. All patients had a depressive 
disorder pre-treatment. Of the six patients that were assessed on the MINI post-treatment, four 
patients still met the criteria for the same depressive disorder, but with two patients the 
treatment program seems to have had an effect on their depressive symptoms as well. One 
patient was mildly depressed at the start of the treatment and at the end of the treatment she 
got the diagnosis ‘depressive episode in early remission’. Another patient was moderately 
depressed at the start of the treatment and did not meet the criteria for any depressive disorder 
at the end of the treatment. Two patients were also diagnosed with a panic disorder with 
agoraphobia at the start of the treatment and one of them did not meet the diagnostic criteria 
for this anxiety disorder anymore. Finally, two patients were diagnosed with a substance use 
disorder at the start of the treatment and one of them also did not meet the criteria for the 
disorder anymore. These results suggest that an intensive EMDR treatment program can also 
have an positive effect on comorbid disorders.   
In order to answer the third research question ‘Does an intensive, inpatient EMDR 
treatment program result in a decrease of psychological distress?’, patients had to fill in a self-
report questionnaire, the BSI, pre-treatment and post-treatment. The results of the study show 
that patients report significantly lower psychological distress two weeks after the treatment 
program compared to the baseline measurement, with large effect sizes. Looking at the 
symptom constructs that constitute psychological distress, patients report significantly less 
anxiety, hostility and psychoticism, with large effect sizes. These results suggest that an 
intensive EMDR treatment program can also have a positive effect on psychological distress.  
This intensive EMDR treatment program also seems to be tolerable. Only one patient 
dropped out of the study and one patient did not attend to the fifth EMDR session, but this 
patient did completed the rest of the treatment program.  
 
4.2 A comparison with earlier studies  
The results of this study are consistent with the literature, in which the effectiveness of 
EMDR for PTSD, comorbid symptoms of depression and anxiety and subjective distress is 
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well established (Chen et al., 2014). The results are also in accordance with the results of 
studies that show that intensive formats of other therapies for PTSD are well tolerated and 
effective. Intensive outpatient prolonged exposure for combat-related PTSD appeared to be 
effective in a case study (Blount et al., 2014), a brief intensive exposure program was 
effective for four patients with a history of childhood sexual abuse (Hendriks et al., 2010), an 
intensive weekend group treatment was effective for 10 veterans with a panic disorder and co-
occurring PTSD (Teng et al., 2015) and a RCT showed that a seven day intensive cognitive 
treatment program is effective for chronic PTSD (Ehlers et al., 2014). Now this study shows 
that an intensive format of EMDR therapy also seems to be an effective and tolerable 
treatment for PTSD, but since this is the first study in which an intensive format of EMDR is 
investigated, more research is necessary.  
 
4.3 Limitations 
This pilot study shows that intensive EMDR treatment can be an effective and tolerable 
treatment for patients with PTSD and comorbid disorders, but the study also has some 
important limitations. First of all, patients did not only receive EMDR treatment, but they also 
received TSY. The decision to incorporate TSY in the treatment program was based on the 
fact that this is the first study in which patients get EMDR treatment in a very intensive 
treatment format, which raised concerns about the tolerability of the treatment program. TSY 
can improve the ability of PTSD patients to tolerate unpleasant feelings (Jindani et al., 2015), 
so the incorporation of TSY in the treatment program can increase the tolerability of the 
program. However, since there are studies that show that TSY can reduce PTSD symptoms 
(Emorson et al., 2009; Clark et al., 2014; Van Der Kolk et al., 2014), it makes it difficult to 
conclude that intensive EMDR treatment alone is an effective and tolerable treatment for 
PTSD. A major drawback of the incorporation of TSY in the treatment program is multiple 
treatment interference, which refers to drawing conclusions about a treatment when this 
treatment is evaluated in the context of other treatments (Kazdin, 2014). This is an external 
validity problem. From this study it can only be concluded that intensive EMDR treatment 
with TSY seems to be an effective and tolerable treatment for PTSD.  
Another limitation of the study is the small sample size, which limits the 
generalizability of the findings. Only seven patients participated in this study and only six 
patients completed the treatment program. Since this is the first study that investigates the 
effectiveness of intensive EMDR treatment, a pilot study with a small sample size is justified, 
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but further investigation of the treatment program in a study with a bigger sample size is 
needed to improve the generalizability of the findings.  
A critical limitation of this study is the absence of a control group. The inclusion of a 
control group rules out al lot of threats to internal validity. For example, the threat history, 
which refers to an event other than the independent variable that may account for the results 
(Kazdin, 2014), can be ruled out when a control group is included because both groups would 
share the effects of these influences. A RCT is needed to rule out the threats to internal 
validity and to ensure that it is the intervention that accounts for the results. 
A final limitation concerns the use of the CAPS-5, the PCL-5 and the MINI. The post-
treatment assessment with the CAPS -5 and the MINI was one week after the last EMDR 
session. The questions that the interviewers asked in these interviews referred to the week 
after the last EMDR session, because the aim of the post-treatment assessment was to 
establish if the patients experienced less PTSD symptoms and symptoms of comorbid 
disorders since the intensive EMDR treatment program and to compare this to the baseline 
assessment. Officially, the questions in these interviews should refer to the past month, but 
this would have included the weeks in which the patients were in treatment and the week 
before the hospitalisation. This is also the case with the PCL-5. The questions in this 
questionnaire should refer to the past month, but in this study the questions referred to the 
period since the last assessment with the PCL-5, because the goal was to establish if the 
patients experienced less PTSD symptoms during the week directly after the hospitalisation 
and during the week after the last EMDR session. In conclusion, the CAPS-5, the PCL-5 and 
the MINI are not used properly in this study, which makes the reliability and validity of the 
outcomes of these assessments questionable. 
 
4.4 Summary and recommendations  
In summary, this pilot study shows that an intensive EMDR program can be an effective 
treatment for different forms of PTSD. When the effectiveness is investigated with a clinical 
interview, an intensive EMDR treatment program reduces all PTSD symptoms and at a self-
report questionnaire, patients report less avoidance and arousal symptoms. An intensive 
EMDR treatment program can also have an effect on comorbid depressive, anxiety and 
substance use disorders and reduces overall psychological distress, anxiety, hostility and 
psychoticism. So, intensive EMDR treatment can be an effective and tolerable treatment for 
patients with PTSD and comorbid disorders, but because of the treatment interference, small 
35 
 
sample size, the absence of a control group and the invalid use of some of the interviews and 
questionnaires, more research is needed.  
 A next study could investigate if intensive EMDR treatment without TSY as 
adjunctive treatment would also be effective, but the importance of eliminating this treatment 
interference effect can be questioned. Establishing that intensive EMDR with TSY as an 
adjunctive treatment is effective and tolerable would already be a great finding, so the benefits 
of establishing if intensive EMDR alone is effective and tolerable should be carefully weight 
against the risk of symptom deterioration, high drop-out and maybe even suicidality. It is 
therefore recommended that a next study also investigates the effectiveness and tolerability of 
intensive EMDR treatment with TSY as adjunctive treatment. Since the results of this small 
pilot study are already so positive, the effectiveness can now be investigated with a RCT. This 
RCT should have a bigger sample size to improve the generalizability of the findings. Finally, 
it is recommended to use the interviews and questionnaires properly in a next study, to ensure 
that the findings are valid.  
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